Xiao-Dong Chen, M.D., Ph.D.

Dr. Chen has spent his entire career studying the incredible potential of stem cells, going back to his University of Nebraska work to identify the embryonic origin of the hematopoietic cells in the liver. His stem cell research continued through postdoctoral work at Yale University and later in his role as a senior fellow at the National Institutes of Health.

Advancing his research as a tenured professor at the University of Texas Health Science Center at San Antonio, Dr. Chen licensed his patents from the university as the foundation of his new company, StemBioSys®. He serves as the company’s Chief Scientific Officer.

Based on his award-winning research, Dr. Chen has authored more than 50 peerreviewed articles related to stem cells, tissue engineering, cellular growth factors and differentiation. He served as the sole editor for the text book “A Roadmap to Nonhematopoietic Stem Cell-Based Therapeutics: From the Bench to the Clinic” (Academic Press. September, 2018).

Dr. Chen completed post-doctoral work at the Yale University School of Medicine. He holds a Ph.D. in developmental immunology and an M.S. in hematology from the University of Nebraska Medical Center, and a medical degree from the Shanghai Jiao-Tong University School of Medicine.